dadstimeon Posted July 20, 2005 Share Posted July 20, 2005 Initial Therapy in Non-Small Cell Lung Cancer http://patient.cancerconsultants.com/lu ... x?id=34588 Lung Cancer News Impressive Results for Addition of Telcyta™ Chemotherapy as Initial Therapy in Non-Small Cell Lung Cancer According to results recently presented at the Eleventh World Conference on Lung Cancer, the addition of Telcyta™ (TLK286) to standard chemotherapy provides impressive anti-cancer responses as initial therapy in advanced non-small cell lung cancer (NSCLC). These results were updated from presentations of the 2005 annual meeting of the American Society of Clinical Oncology (ASCO), held in May 2005. Lung cancer is the leading cause of cancer-related deaths in the United States and Europe. NSCLC, which arises from the tissues of the lung, is the most common type of lung cancer. Under most circumstances, NSCLC is not curable. Current treatments include surgery and chemotherapy. Chemotherapy is often prescribed in the treatment of NSCLC and is designed to reduce or limit the growth of cancer cells. Stages IIB and IV NSCLC are advanced stages and refer to cancer that has spread from its site of origin to distant and/or several sites in the body. Telcyta is a new drug that is considered a “prodrug†Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.